Wolverine Asset Management LLC Ligand Pharmaceuticals Inc Put Options Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 13, 2020	SELL	$89.56 - $126.72 $1.64 Million - $2.32 Million	-18,300 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$68.28 - $123.65 $1.21 Million - $2.19 Million	-17,700 Reduced 49.17%	18,300 $2.05 Million
Q1 2020 May 13, 2020	SELL	$63.37 - $107.88 $126,740 - $215,760	-2,000 Reduced 5.26%	36,000 $2.62 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $3.61 Million - $4.23 Million	-37,200 Reduced 49.47%	38,000 $3.96 Million
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $5.25 Million - $7.32 Million	60,900 Added 425.87%	75,200 $7.49 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $1.81 Million - $2.19 Million	-16,900 Reduced 54.17%	14,300 $1.63 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $3.31 Million - $4.45 Million	31,200 New	31,200 $3.92 Million

276

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.